Kexin Zhu1, Jean Wactawski-Wende1, Heather M Ochs-Balcom1, Michael J LaMonte1, Kathleen M Hovey1, William Evans2,3, Mahalakshmi Shankaran3, Bruce R Troen4, Hailey R Banack1. 1. Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, The State University of New York, USA. 2. Division of Geriatrics, Duke University Medical Center, Durham, North Carolina, USA. 3. Department of Nutritional Sciences and Toxicology, University of California, Berkeley, USA. 4. Division of Geriatrics and Palliative Medicine, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo and Research Service, Veterans Affairs Western New York Healthcare System, USA.
Abstract
BACKGROUND: The D3-creatine (D3Cr) dilution method provides a direct measure of skeletal muscle. The aim of this study was to compare the association of D3Cr muscle mass with lean body mass (LBM) measured by dual-energy x-ray absorptiometry (DXA) and examine its relation with physical function in postmenopausal women. METHODS: Seventy-four community-dwelling women (mean age 82.3 ± 5.4) participated in this pilot study from the Buffalo, New York clinical site of the Women's Health Initiative (WHI). Participants attended a clinic visit which included anthropometric measures, blood draw, DXA scan, measures of physical function, and initiated the D3Cr protocol. Physical function was evaluated using hand grip strength, short physical performance battery (SPPB), and RAND-36 physical function scale. Descriptive statistics and logistic regression models were used to examine the associations of D3Cr muscle mass with functional outcomes. RESULTS: D3-creatine muscle mass was moderately correlated with DXA LBM (r = 0.50) and DXA appendicular lean mass (ALM) (r = 0.50). Individuals with high D3Cr muscle mass (%) had higher physical function compared to individuals with low muscle mass (%), indicated by high scores on SPPB (odds ratio [OR] = 5.24; 95% confidence interval [CI]: 1.40, 19.58). We observed stronger relationships between high D3Cr and physical function than either DXA LBM (OR = 3.40; 95% CI: 0.88, 13.11) or DXA ALM (OR = 4.15; 95% CI: 1.10, 15.68) and physical function. CONCLUSIONS: Our findings provide strong preliminary data for the associations of D3Cr muscle mass with measures of physical function in older women. These findings support and extend prior work on D3Cr muscle mass in older men.
BACKGROUND: The D3-creatine (D3Cr) dilution method provides a direct measure of skeletal muscle. The aim of this study was to compare the association of D3Cr muscle mass with lean body mass (LBM) measured by dual-energy x-ray absorptiometry (DXA) and examine its relation with physical function in postmenopausal women. METHODS: Seventy-four community-dwelling women (mean age 82.3 ± 5.4) participated in this pilot study from the Buffalo, New York clinical site of the Women's Health Initiative (WHI). Participants attended a clinic visit which included anthropometric measures, blood draw, DXA scan, measures of physical function, and initiated the D3Cr protocol. Physical function was evaluated using hand grip strength, short physical performance battery (SPPB), and RAND-36 physical function scale. Descriptive statistics and logistic regression models were used to examine the associations of D3Cr muscle mass with functional outcomes. RESULTS: D3-creatine muscle mass was moderately correlated with DXA LBM (r = 0.50) and DXA appendicular lean mass (ALM) (r = 0.50). Individuals with high D3Cr muscle mass (%) had higher physical function compared to individuals with low muscle mass (%), indicated by high scores on SPPB (odds ratio [OR] = 5.24; 95% confidence interval [CI]: 1.40, 19.58). We observed stronger relationships between high D3Cr and physical function than either DXA LBM (OR = 3.40; 95% CI: 0.88, 13.11) or DXA ALM (OR = 4.15; 95% CI: 1.10, 15.68) and physical function. CONCLUSIONS: Our findings provide strong preliminary data for the associations of D3Cr muscle mass with measures of physical function in older women. These findings support and extend prior work on D3Cr muscle mass in older men.
Authors: Richard V Clark; Ann C Walker; Robin L O'Connor-Semmes; Michael S Leonard; Ram R Miller; Stephen A Stimpson; Scott M Turner; Eric Ravussin; William T Cefalu; Marc K Hellerstein; William J Evans Journal: J Appl Physiol (1985) Date: 2014-04-24
Authors: Peggy M Cawthon; Terri Blackwell; Steven R Cummings; Eric S Orwoll; Kate A Duchowny; Deborah M Kado; Katie L Stone; Kristine E Ensrud; Jane A Cauley; William J Evans Journal: J Gerontol A Biol Sci Med Sci Date: 2021-01-01 Impact factor: 6.053
Authors: Eric S Orwoll; Katherine E Peters; Marc Hellerstein; Steven R Cummings; William J Evans; Peggy M Cawthon Journal: J Gerontol A Biol Sci Med Sci Date: 2020-06-18 Impact factor: 6.053
Authors: Kristine E Ensrud; Susan K Ewing; Brent C Taylor; Howard A Fink; Katie L Stone; Jane A Cauley; J Kathleen Tracy; Marc C Hochberg; Nicolas Rodondi; Peggy M Cawthon Journal: J Gerontol A Biol Sci Med Sci Date: 2007-07 Impact factor: 6.053
Authors: Tara S Rogers-Soeder; Katherine E Peters; Nancy E Lane; James M Shikany; Suzanne Judd; Lisa Langsetmo; Andrew R Hoffman; William J Evans; Peggy M Cawthon Journal: J Gerontol A Biol Sci Med Sci Date: 2020-06-18 Impact factor: 6.053
Authors: Kate A Duchowny; Katherine E Peters; Steven R Cummings; Eric S Orwoll; Andrew R Hoffman; Kristine E Ensrud; Jane A Cauley; William J Evans; Peggy M Cawthon Journal: J Cachexia Sarcopenia Muscle Date: 2019-10-17 Impact factor: 12.910
Authors: Peggy M Cawthon; Katherine E Peters; Steven R Cummings; Eric S Orwoll; Andrew R Hoffman; Kristine E Ensrud; Jane A Cauley; William J Evans Journal: J Bone Miner Res Date: 2022-03-06 Impact factor: 6.390